| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.49B | 61.60B | 57.88B | 60.72B | 55.26B | 53.34B |
| Gross Profit | 16.22B | 15.83B | 14.24B | 14.70B | 13.18B | 14.85B |
| EBITDA | 4.82B | 4.72B | 5.34B | 5.73B | 4.43B | 6.09B |
| Net Income | 1.69B | 1.96B | 1.99B | 1.55B | 451.28M | 1.66B |
Balance Sheet | ||||||
| Total Assets | 70.53B | 70.88B | 68.32B | 63.68B | 58.23B | 55.44B |
| Cash, Cash Equivalents and Short-Term Investments | 6.38B | 6.94B | 6.92B | 6.77B | 5.23B | 5.54B |
| Total Debt | 25.87B | 26.08B | 25.37B | 20.98B | 17.44B | 15.92B |
| Total Liabilities | 38.93B | 38.89B | 37.77B | 35.24B | 30.72B | 27.76B |
| Stockholders Equity | 31.60B | 31.99B | 30.53B | 28.43B | 27.50B | 27.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -156.61M | -3.67B | -824.96M | -578.13M | 1.97B |
| Operating Cash Flow | 0.00 | 5.42B | 1.69B | 2.69B | 2.71B | 5.29B |
| Investing Cash Flow | 0.00 | -5.56B | -5.33B | -3.72B | -3.66B | -4.68B |
| Financing Cash Flow | 0.00 | -104.00M | 3.65B | 2.54B | 583.07M | -157.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥697.04B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
76 Outperform | ¥225.52B | 22.19 | ― | 1.88% | 6.56% | 106.55% | |
74 Outperform | ¥7.38T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
74 Outperform | ¥83.69B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
64 Neutral | ¥168.70B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥20.91B | 7.82 | ― | 3.88% | 5.14% | 18.52% |